Chemotherapy of canine and feline neoplasia*

Bostock, D. E.; Owen, L.N.

doi:10.1111/j.1748-5827.1972.tb06861.x

Cited by 6 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In April 1972, BSAVA hosted a symposium on “The treatment of malignant neoplasms” at its 15th Annual Congress in London and papers subsequently published in JSAP by Silver , Bostock & Owen and Baker () described the use of radiotherapy for the treatment of neoplasia, chemotherapy of canine and feline neoplasia and surgical management respectively. However, although the basic principles underpinning the use of these modalities was understood, all concluded that the veterinary literature at that time was deficient in follow‐up surveys documenting response to treatment and outcomes and called for clinical research to establish the efficacy of these treatment in small animal oncology.…”

Section: Introductionmentioning

confidence: 99%

Significant advances in veterinary oncology – 60 years on

Dobson

2019

J of Small Animal Practice

View full text Add to dashboard Cite

The first edition of the Journal of Small Animal Practice published in February 1960, contained a paper entitled “Recent Treatments of Malignant Neoplasia” by Dr Larry Owen. Now we have reached the 60th anniversary of JSAP, that article provides a baseline from which to review subsequent advances in veterinary oncology, which now includes worldwide networks that have resulted in veterinary oncology becoming the multidisciplinary speciality that it is today. There certainly have been many advances in understanding of the pathology and epidemiology of animal cancers and in methods of diagnosis and treatment. However, the subject has become so large and diverse that not all aspects can be covered in detail here. It should also be acknowledged that there are still many gaps in knowledge in this field and that, because of a lack of randomised clinical trials, the evidence base for what is often regarded as “standard of care” is weak.

show abstract

Section: Introductionmentioning

confidence: 99%